Novartis | Patient Daily

Novartis

Patient Daily | May 7, 2023

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa

Patient Daily | May 7, 2023

Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO

Patient Daily | May 7, 2023

Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients

Patient Daily | May 7, 2023

Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance

Carol Ostrow | Feb 7, 2019

Novartis says Cosentyx better at clearing skin in psoriasis patients than Stelara

Press release submission | Dec 5, 2018

NOVARTIS: Announces longer-term analyses from pivotal Kymriah® trials that showed durable responses are maintained in patients with advanced blood cancers

Press releases submission | May 15, 2018

NOVARTIS: Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally

Carrie Bradon | Dec 1, 2017

Novartis announces positive results of MONALEESA-7 trial

Trending

Patient Daily | Mar 27, 2025

Healthcare professionals recognized at National Breathe Free conference for outstanding dedication

Patient Daily News Service | Mar 28, 2025

Former HHS Official: '340B program is just one of many reminders of the abuse and waste' in D.C.

+ Pharmaceuticals

Patient Daily | Mar 31, 2025

Founder of RXSaveCard on drug pricing: 'We typically see savings of $6,000+ per prescription'

+ Pharmaceuticals

Patient Daily | Apr 1, 2025

American Lung Association responds to HHS budget cuts